NevBio Luncheon – “New Treatment for Sepsis” by Dr. Robert J. Webber – Sep 25
“New Treatment for Sepsis” by Dr. Robert J. Webber, CEO of DSX Therapuetics, Inc.
Dr. Robert J. Webber is the founder and CEO of DSX Therapeutics, Inc. Dr. Webber was trained at the UCLA School of Medicine in the Department of Biological Chemistry. He was the founder, CEO and Chief Scientific Officer of Research & Diagnostic Antibodies®, the parent company of DSX Therapeutics, Inc. He is a pioneer in producing monoclonal antibodies, their use in diagnostic tests, and their utility as highly targeted treatments of disease. Dr. Robert Webber is the inventor or co-inventor of four issued patents and 13 pending US and foreign patent applications.
Thursday, September 25th
11:30 Check-in, 12:00 Noon Meeting & Lunch
NEW LOCATION – Sunrise Hospital – Auditorium 3186 South Maryland Parkway Las Vegas
To RSVP by phone, call Judy at 839-7222 or email jrebholz@cvbt.com
To RSVP and Pay Online
